SAMD9L and Pancytopenia: Germline gain-of-function (GOF) mutations, therefore, increase SAMD9 or SAMD9L antiproliferative effect causing pancytopenia, BMF and generally restricted growth and/or specific organ hypoplasia in non-hematopoietic tissues in an autosomal dominant fashion [44].